GMT Data

AB&B BIO-TECH-B (02627)

AuditorFromToRelease Date / Document LinksReason for Change
Prism Hong Kong Ltd
Deloitte13-Apr-26Deloitte Touche Tohmatsu expressed grave concerns over the commercial substance and business rationale of the Fund Investments and the Consultancy Payments arrangements and recommended the Audit Committee to initiate an independent investigation into these matters. Given the serious nature of the matters, DTT reiterated their view recommending Audit Committee to initiate an investigation by an independent forensic investigation firm is necessary in order for the Company to have a robust basis for concluding on the matters. DTT stated that they were informed on April 1, 2026 that the Company has decided to engage a new auditor for the 2025 Audit, the effect of this would be that they will not be able to complete the 2025 Audit and to fulfil their public interest obligation to report to the Shareholders. DTT stated that after careful consideration, they have concluded that the decision of the Company to engage a new auditor has made their professional relationship untenable and accordingly, they have decided to tender their resignation as auditor at the Company’s request.